EXIQON Logo (USPTO, 10.10.2007)
USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke EXIQON wurde als Bildmarke am 10.10.2007 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "IR CANCELED; US APPLICATION ABANDONED".
Markeninhaber
Trørød DK-2950 Vedbæk
Markenvertreter
Waren und Dienstleistungen
1
Chemical products for diagnostic, industrial and scientific purposes, namely, for analyses of genes and molecules; biochemical reagents for scientific and research analyses of nucleic acids, nucleotides, oligonucleotides, DNA and RNA; chemical reagents for other than medicinal and veterinary purposes; biochemical reagents commonly known as probes, for analyses of genes, nucleotides, oligonucleotides, nucleic acids sequences for other than medical and veterinary purposes, namely, for detecting DNA, RNA and microRNA; biochemical kits comprising chemical reagents, not for medicinal and veterinary purposes, for analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA
5
Chemical reagents for medicinal or veterinary use; chemical preparations for pharmaceutical, medicinal or veterinary use, namely, kits comprising reagents for medical, veterinary and diagnostic use, commonly known as probes and arrays, for analyses of genes, molecules, protein, DNA, nucleic acid, nucleotides and oligonucleotides, and for detecting DNA, RNA and microRNA; chemical reagents for pharmaceutical use, namely, kits comprising reagents for medical, veterinary and diagnostic use, commonly known as probes and arrays, for analyses of genes, molecules, protein, DNA, nucleic acid, nucleotides and oligonucleotides, and for detecting DNA, RNA and microRNA; chemical reagents for medicinal and veterinary purposes
42
Research, development, non-business consultancy services in the field of chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; biotechnological consultancy in the field of DNA, peptide and nucleotide syntheses
45
Patent utilization, namely, licensing of patents
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379047167